These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 2887612)
1. Famotidine: an evolution in H2 antagonist therapy. Proceedings of a symposium. São Paulo, Brazil, September 7-12, 1986. J Clin Gastroenterol; 1987; 9 Suppl 2():1-27. PubMed ID: 2887612 [No Abstract] [Full Text] [Related]
2. Proceedings of a satellite symposium on famotidine: further developments in H2-receptor antagonist therapy. World Congresses of Gastroenterology meeting. São Paulo, Brazil, 12 September 1986. Scand J Gastroenterol Suppl; 1987; 134():1-62. PubMed ID: 2889254 [No Abstract] [Full Text] [Related]
3. A review of developments in H2-receptor antagonist therapy: focus on famotidine. Proceedings of an official satellite symposium to the 8th Asian-Pacific Congress on Gastroenterology and the 5th Asian-Pacific Congress of Digestive Endoscopy. Seoul, Korea, 10 October 1988. J Int Med Res; 1989; 17 Suppl 1():1A-53A. PubMed ID: 2566538 [No Abstract] [Full Text] [Related]
4. Famotidine: clinical applications of a new H2-receptor antagonist. May 16, 1986, Carmel, California. Am J Med; 1986 Oct; 81(4B):1-64. PubMed ID: 2877568 [No Abstract] [Full Text] [Related]
5. Famotidine in the USA: a review of efficacy studies. Gitnick G J Int Med Res; 1989; 17 Suppl 1():17A-24A. PubMed ID: 2566539 [TBL] [Abstract][Full Text] [Related]
6. Treatment of upper gastro-intestinal bleeding with the H2-receptor antagonist famotidine. Aoki T J Int Med Res; 1989; 17 Suppl 1():32A-40A. PubMed ID: 2566542 [TBL] [Abstract][Full Text] [Related]
8. [Famotidine. Pharmacologic and clinical profile of the new histamine H2 receptor antagonist]. Müller P; Dammann HG; Simon B Fortschr Med; 1986 Apr; 104(15):319-22. PubMed ID: 2872147 [No Abstract] [Full Text] [Related]
9. Famotidine: a further development in the modern treatment of peptic ulcer disease. Proceedings of a satellite symposium of the XIIth International Congress of Gastroenterology. Lisbon, September 19, 1984. Digestion; 1985; 32 Suppl 1():1-72. PubMed ID: 2866131 [No Abstract] [Full Text] [Related]
10. Drugs recently released in Belgium. Recombinant DNA tissue plasminogen activator (rt-PA) famotidine-sultamicillin. Harvengt C Acta Clin Belg; 1988; 43(5):396-400. PubMed ID: 2905106 [No Abstract] [Full Text] [Related]
11. Famotidine: clinical applications of a new H2-receptor antagonist. Introduction. Texter EC Am J Med; 1986 Oct; 81(4B):1-2. PubMed ID: 2877567 [No Abstract] [Full Text] [Related]
12. [Clinical aspects of Kvamatel (famotidine) administration]. Golochevskaia VS Klin Med (Mosk); 1996; 74(1):45-7. PubMed ID: 8649009 [No Abstract] [Full Text] [Related]
13. A single nocte dose of famotidine in the treatment of duodenal ulcer. Qureshi H; Ahmad W; Zuberi SJ J Pak Med Assoc; 1989 Apr; 39(4):104-6. PubMed ID: 2568508 [TBL] [Abstract][Full Text] [Related]
14. [Comparison of famotidine and ranitidine in duodenal ulcer]. Rohner HG; Gugler R; Kimmig JM; Schönekäs H Dtsch Med Wochenschr; 1987 Feb; 112(9):367-8. PubMed ID: 2880704 [No Abstract] [Full Text] [Related]
15. [Ebrotidine: an new alternative in peptic acid diseases]. Piqué JM Med Clin (Barc); 1997 Mar; 108(8):301-3. PubMed ID: 9121207 [No Abstract] [Full Text] [Related]
16. Famotidine (Pepcid). Med Lett Drugs Ther; 1987 Feb; 29(733):17-8. PubMed ID: 2880282 [No Abstract] [Full Text] [Related]